首页/数据集/Characteristics of patients with indeterminate serostatus against hepatitis B virus.

Characteristics of patients with indeterminate serostatus against hepatitis B virus.

Figshare2025-11-20 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Characteristics_of_patients_with_indeterminate_serostatus_against_hepatitis_B_virus_/30668622 数据链接链接失效反馈

官方服务：

资源简介：

Characteristics of patients with indeterminate serostatus against hepatitis B virus.

应用场景：

创建时间：

2025-11-20

相关数据集

Hepatitis B Diagnostic Tests Market

乙型肝炎诊断

医疗市场分析

Report of Hepatitis B Diagnostic Tests Market is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an important part in the i

IMR REPORTS80

North America Hepatitis B Diagnostic Tests Market

乙型肝炎诊断

医疗市场分析

The North America Hepatitis B Diagnostic Tests report features an extensive regional analysis, identifying market penetration levels across major geographic areas. It highlights regional growth trends

IMR REPORTS50

Analytical precision of determination of HBsAg in human serum (n = 20).

乙型肝炎诊断

血清标志物

Analytical precision of determination of HBsAg in human serum (n = 20).

Figshare2015-12-03 更新30

Hepatitis B Diagnostic Tests Market by Product Type (Point-of-care Testing Kits [Cassettes/Cards and Strips] and Enzyme Immunoassay Kits [Anti-hepatitis B core antibody test, Hepatitis B surface antigen test, Anti-hepatitis B surface antibody test]) and by End User (Hospitals, Diagnostic Centers, Clinics, and Home Care), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast 2024-2032

乙型肝炎诊断

市场分析

Global Hepatitis B Diagnostic Tests market size earned around $1647.58 M in 2023 and is expected to hit $2,021.75 M by 2032, with a projected CAGR of 2.30%.

www.zionmarketresearch.com2024-11-25 更新60

Table1_Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis.XLSX

纤维化生物标志物

乙型肝炎诊断

Hepatitis B virus (HBV) infection remains the leading cause of liver fibrosis (LF) worldwide, especially in China. Identification of decisive diagnostic biomarkers for HBV-associated liver fibrosis (H

NIAID Data Ecosystem40